Sevelamer Carbonate Tablet, Film Coated
Product Images NDC 55154-8188

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sevelamer Carbonate (NDC 55154-8188). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bag Label (61d073ec 51a4 48c7 8762 25fdd00fe6ac 00)

Sevelamer Carbonate Tablets 800 mg film-coated oral tablets in a package of 10 tablets. The label includes active ingredient information, a list of inactive ingredients, storage instructions, dosage directions to see the product insert, and warnings about child resistance and protection. The labeler is Cardinal Health 107, LLC, with distribution by American Health Packaging and Cardinal Health.*

FDA Label Image

Figure 3 (Sevelamer Fig1)

A line graph illustrating the percentage of patients (Y-axis) achieving a reduction in serum phosphorus (X-axis, mg/dL) at least as great as specified. Two lines compare 'Sevelamer Hydrochloride' and 'Active Control' across a range of phosphorus reduction values from -4 to 8 mg/dL. The X-axis denotes worsening increase and improved reduction regions.*

FDA Label Image

Figure 4 (Sevelamer Fig2)

A line graph showing mean phosphorus change from baseline over 52 weeks for patients treated with Sevelamer Hydrochloride compared to an active control. The y-axis represents phosphorus change from baseline, ranging from -5 to 2, and the x-axis represents study weeks from 0 to 52. The graph depicts the phosphorus change decreasing initially and stabilizing during the treatment period for both groups.*

FDA Label Image

Chemical Structure (Sevelamer Str)

Chemical structure of Sevelamer Carbonate showing its polymer network with primary amine groups, crosslinking groups, and carbonate ions. The diagram includes annotations for primary amine groups (a, b), crosslinking groups (c), and overall polymer length (m) indicative of the extended polymer network.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.